arritmia cardíaca com uso de oxamniquine oral no tratamento de esquistossomose mansônica cardiac arrhythmia with oral oxamniquine in the treatment of schistosomiasis mansoni
Article Quality & Performance Metrics
Readership in this journal
SteadyRanked #104 of 173 articles by views in 2017 12th international conference for internet technology and secured transactions, icitst 2017
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 173 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
The authors report a case of a patient with schistosomiasis (S.mansoni) treated with one single dose (15 mg/kg/BWT) of oral oxamniquine who presented Mobitz type I second-degree AV block and sinus arrest with ventricular escape as a side-effect. They conclude that in spite of the safety and good activity of oxamniquine it may be a determinant of cardiotoxicity
| Reference Key |
guitti1993revistaarritmia
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | |
| Journal | 2017 12th international conference for internet technology and secured transactions, icitst 2017 |
| Year | 1993 |
| DOI |
10.1590/S0036-46651993000600018
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
ZincirX productsfrom the team behind Journament
-
PatentYazar
Patent drafts for the EPO, USPTO and TürkPatent
From inventor notes to a DOCX draft: description, claims, abstract. The machine drafts, the attorney signs.
See how it works (opens in a new tab) -
Projenator
Have a project idea? Score and plan it with AI
AI scores your idea in five dimensions and builds a phased plan. Your first project is free, no card needed.
Start your first project (opens in a new tab)
Cookies
We use strictly necessary cookies to run the site and keep you signed in. With your permission we would also use Google Analytics to see how the site is used, and Google AdSense to show ads on journal and article pages. Both stay off unless you accept, and you can change your mind at any time. How we use cookies · KVKK notice (Türkiye)
Cookie settings
Comments
No comments yet. Be the first to comment on this article.